Clinical Trial Update: Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 1/2 safety and tolerability study of oral EUR-1100 for eosinophilic esophagitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• EUR-1100

Snippet

Sponsor: Forest Laboratories | Conditions: Eosinophilic Esophagitis | Phase 1, Phase 2 | Status: COMPLETED